Irvine, Calif.–(ANTARA/Enterprise Wire)–SBC Medical Group Holdings Included (Nasdaq: SBC) (“SBC Medical” or the “Firm”), a Medical Providers Group (MSO) offering administration help throughout a variety of healthcare fields to medical establishments in Japan and overseas, immediately introduced its consolidated monetary outcomes for the second quarter of fiscal 12 months 2026 (the three months ended June 30, 2026) and the primary half of fiscal 12 months 2026 (the six months ended June 30, 2026).
Second Quarter 2026 Monetary Highlights
The Firm believes the quarter marked a transparent reacceleration in its development, with web earnings attributable to SBC Medical development outpacing income development. Earnings development was supported by the growth of the factors enterprise following a change within the Firm’s working coverage and the growth of service charges consistent with enhanced AI-enabled help capabilities.
The enterprise of the medical companies the Firm helps additionally continued to broaden steadily. As of the top of June 2026, the variety of places2 elevated by 34 year-over-year to 287, and last-twelve-month variety of visits3 reached 6.9 million (up 10% year-over-year). Common spend per go to was $287, up 9% year-over-year.
Remark from SBC Medical’s Chairman and CEO Yoshiyuki Aikawa:
“We imagine our outcomes this quarter clearly exhibit that SBC Medical’s development story has entered a brand new section. Having accomplished the structural reforms we undertook in 2025, we are actually working a number of development engines concurrently. I’m rising more and more assured that this reacceleration will not be a short lived phenomenon however displays the strengthening of our underlying development fundamentals.
What offers me the best confidence is that the convergence of healthcare and AI is changing into one among SBC Medical’s subsequent sources of aggressive benefit. We’re leveraging greater than 26 years of accrued administration knowledge to help AI improvement and implementing mechanisms that improve clinic operations — together with AI-powered name facilities, AI-driven advertising and marketing, and AI-assisted web site choice for brand spanking new clinic openings.
Strengthening our AI-enabled MSO platform concurrently drives development throughout three dimensions: the variety of clinic places, common payment per clinic (AFPC), and repair menu breadth. Because the platform’s attraction grows, affected person visits and therapy volumes on the clinics we help improve, accelerating clinic development — which in flip results in expanded service charges commensurate with the worth we offer. We imagine this virtuous cycle is the driving pressure behind sustainable development in consolidated income and EPS, as mirrored in our most up-to-date reported historic outcomes and sooner or later.
Particularly, by means of payment revisions for our name middle providers offered to 5 particular affiliated medical companies, along with separate payment revisions reflecting expanded help for Rize Clinic and Gorilla Clinic, we count on these initiatives, if their influence is realized for a full 12 months, to extend service charges by roughly $15 million yearly (transformed at ¥158.1/US$). These initiatives are being pursued in a disciplined method, premised on a win-win relationship between the Firm and our affiliated medical companies.
Wanting forward, we’ll deepen our multi-brand technique in aesthetic dermatology domestically, whereas increasing our non-aesthetic enterprise, which we place as our “second development engine.” Internationally, we plan to speed up our world development by means of our collaboration with OrangeTwist in the USA and our ASEAN growth, anchored in Thailand. We’re additionally making ready to enter the Longevity market, which we see as having monumental potential.
With $184 million in money and money equivalents readily available, we’ll proceed to pursue disciplined funding towards our subsequent development section. By pursuing sustained EPS development and reaching honest fairness valuation for our shares within the capital markets as two wheels of the identical cart, we goal to ship even better worth to all our stakeholders, together with our shareholders. We sit up for what lies forward for SBC Medical.”
Abstract of Key Financials
Unit
2Q26
2Q25
YoY
1H26
1H25
YoY
Whole revenues
$MM
49
43
+13%
92
91
+2%
Internet Earnings Attributable to SBC Medical
$MM
11
2
+335%
22
24
(8)%
Internet Earnings Margin
%
22
6
+16pt
24
26
(2)pt
Adjusted EBITDA
$MM
20
15
+32%
38
40
(4)%
Adjusted EBITDA Margin
%
41
35
+6pt
42
44
(2)pt
ROE (Annualized)
%
16
4
+12pt
17
22
(5)pt
Primary EPS
$
0.10
0.02
+400%
0.21
0.23
(9)%
Convention Name
The Firm will maintain a convention name on Thursday, August thirteenth, 2026 at 08:30 a.m. Japanese Time (or Thursday, August thirteenth, 2026 at 09:30 p.m. Japan Time) to debate the monetary outcomes for the second quarter ended June 30, 2026. An issue-and-answer session will observe the ready remarks.
Through the stay webcast, contributors might submit questions in real-time utilizing the Zoom Q&A button.
All attendees, no matter their present inventory possession standing, are welcome to submit questions. Please be aware that as a consequence of time constraints and the character of the inquiries, we might not be capable to handle each query throughout the name.
Please register prematurely of the convention utilizing the hyperlink offered beneath:
https://zoom.us/webinar/register/WN_sEGnJWOyQDejlpnuGnxQgA
Upon registration, it is possible for you to to entry the devoted convention name viewing web site.
Moreover, the earnings launch, accompanying slides, and a separate hyperlink to the archived webcast of this convention name might be accessible on the Firm’s Investor Relations web site at https://ir.sbc-holdings.com/.
About SBC Medical
SBC Medical is a Medical Providers Group offering administration help throughout a variety of healthcare fields, together with superior aesthetic healthcare, dermatology, orthopedics, fertility therapy, gynecology, dentistry, alopecia therapy (AGA), and ophthalmology. The Firm manages a various portfolio of clinic manufacturers and is actively increasing its world presence, significantly in the USA and Asia, by means of each direct operations and medical tourism initiatives. In September 2024, the Firm was listed on Nasdaq, and in June 2025, it was chosen for inclusion within the Russell 3000® Index, a broad benchmark of the U.S. fairness market. Guided by its Group Objective “Contributing to the well-being of individuals all over the world by means of medical innovation,” SBC Medical continues to offer secure, trusted, and high-quality medical providers whereas additional strengthening its worldwide popularity for high quality and belief in medical care.
Firm Title: SBC Medical Group Holdings Included | Listed Market: NASDAQ World Market | Ticker: SBC | Deal with: 200 Spectrum Heart Drive, Suite 300, Irvine, CA 92618 USA | IR Web site: https://ir.sbc-holdings.com/ | LinkedIn: https://www.linkedin.com/firm/sbc-medical-group-holdings-inc
Use of Non-GAAP Monetary Measures
The Firm makes use of non-GAAP measures, akin to Adjusted EBITDA, Adjusted EBITDA margin, in evaluating its working outcomes and for monetary and operational decision-making functions. The Firm believes that the non-GAAP monetary measures assist determine underlying developments in its enterprise, present helpful details about the Firm’s outcomes of operations, improve the general understanding of the Firm’s previous efficiency and future prospects, and permit for better visibility with respect to key metrics utilized by the Firm’s administration in its monetary and operational decision-making.
The non-GAAP monetary measures will not be outlined below U.S. GAAP and will not be introduced in accordance with U.S. GAAP. The displays of those measures have limitations as analytical instruments and shouldn’t be thought-about in isolation or as an alternative to evaluation of our outcomes as reported below GAAP. As a result of not all firms use an identical calculations, the displays of those measures might not be akin to different equally titled measures of different firms and might differ considerably from firm to firm. For reconciliations of those non-GAAP monetary measures to probably the most immediately comparable GAAP measures, see the reconciliations included on the finish of this press launch.
Ahead-Wanting Statements
This press launch incorporates forward-looking statements. Ahead-looking statements will not be historic information or statements of present circumstances, however as a substitute signify solely the Firm’s beliefs relating to future occasions and efficiency, lots of which, by their nature, are inherently unsure and out of doors of the Firm’s management. These forward-looking statements mirror the Firm’s present views with respect to, amongst different issues, the Firm’s plans and techniques for service growth; development in income and earnings; and enterprise prospects. In some circumstances, forward-looking statements might be recognized by means of phrases akin to “might,” “ought to,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets,” or “hopes” or the adverse of those or comparable phrases. The Firm cautions readers to not place undue reliance upon any forward-looking statements, that are present solely as of the date of this launch and are topic to varied dangers, uncertainties, assumptions, or adjustments in circumstances which can be troublesome to foretell or quantify. The forward-looking statements are primarily based on administration’s present expectations and will not be ensures of future efficiency. The Firm doesn’t undertake or settle for any obligation to launch publicly any updates or revisions to any forward-looking statements to mirror any change in its expectations or any change in occasions, circumstances, or circumstances on which any such assertion relies, besides as required by regulation. Elements which will trigger precise outcomes to vary materially from present expectations might emerge on occasion, and it isn’t doable for the Firm to foretell all of them; such elements embody, amongst different issues, adjustments in world, regional, or native financial, enterprise, aggressive, market and regulatory circumstances, and people listed below the heading “Threat Elements” and elsewhere within the Firm’s filings with the U.S. Securities and Alternate Fee (the “SEC”), that are accessible on the SEC’s web site at www.sec.gov.
To view the whole model of this launch, please click on right here
Contacts
SBC Medical Group Holdings Included — Hikaru Fukui / Head of IR Division; E-mail: ir@sbc-holdings.com
Supply: SBC Medical Group Holdings Included
Reporter: PR Wire
Editor: PR Wire
Copyright © ANTARA 2026
